# Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer

> **NCT05959889** · NA · COMPLETED · sponsor: **Damanhour University** · enrollment: 50 (actual)

## Conditions studied

- Breast Cancer
- Doxorubicin Induced Cardiotoxicity

## Interventions

- **DRUG:** AC protocol
- **DRUG:** Montelukast

## Key facts

- **NCT ID:** NCT05959889
- **Lead sponsor:** Damanhour University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05959889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05959889, "Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05959889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*